🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Effect of Bubble Positive Expiratory Pressure and Segmental Breathing Versus Incentive Spirometry in Pleural Effusion

RecruitingNAAges 5 Years - 16 YearsAllRiphah International University
NCT07248774 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Conducted as a randomized clinical trial, this study will include 40 pediatric participants aged 5-16, recruited from Gulab Devi Chest Hospital and Children's Hospital, Lahore. Participants will be randomly divided into two groups: one receiving Bubble PEP with Segmental Breathing and the other using Incentive Spirometry, both combined with conventional chest physiotherapy and mobility. Outcome measures, including lung expansion (via X-ray), dyspnea (assessed using the Pediatric Dyspnea Scale), chest expansion (measured with a measuring tape), oxygen saturation (SpO₂), and respiratory rate, will be recorded pre- and post-intervention. The study hypothesises that the Bubble PEP and Segmental Breathing approach may offer a cost-effective and efficient alternative to Incentive Spirometry, particularly for patients who cannot afford mechanical devices. Statistical analysis will be performed

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age 5 to 16. * Suffering from Pleural effusion or hydrothorax. * Thoracic drainage system in situ for 24 hours. * Either gender will be included. * Patients without any other co-existing illness. Exclusion Criteria: * Any other pulmonary pathology that does not fit the diagnostic criteria of Pleural Effusion. * Participants with unbearable chest pain, chylothorax, hemothorax, pneumothorax, chest trauma or rib fracture. * Participants with other comorbidities leading to pleural effusion. * Patients who have chest musculoskeletal deformities.
💊

What it tests

  • Bubble PEP
  • Incentive Spirometery
📍

Where

1 site
The Children Hospital and University of Child Health Sciences
Lahore, Pakistan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy